Samarth Kulkarni
CIK 1682019 · Chief Executive Officer · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$16.99M
Companies
6
Total Filings
110
Lifetime Open-Market Net
-$65.03M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ORKA | Director | — | $69.89 | — | $0 | 2 | 2026-06-03 |
| CRSP | Chief Executive Officer | 341,123 | $49.80 | $16.99M | -$64.02M | 87 | 2026-03-24 |
| CNTA | Director | — | $39.72 | — | $0 | 4 | 2025-06-24 |
| BDTX | Director | — | $1.75 | — | $0 | 6 | 2025-06-12 |
| Repare Therapeutics Inc. (RPTX) Delisted | Director | — | $2.65 | — | $0 | 4 | 2024-06-20 |
| CRISPR Therapeutics AG (PZRX) Delisted | Chief Executive Officer | 148,560 | — | — | -$1.01M | 7 | 2017-12-26 |
Recent Filings · Page 11 of 11
110 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-04-18 | CRSP | Grant (A) | — | $0 | EDGAR |
| 2018-03-14 | CRSP | Grant (A) | — | $0 | EDGAR |
| 2018-03-09 | CRSP | Grant (A) | — | $0 | EDGAR |
| 2017-12-26 | CRISPR Therapeutics AG (PZRX) Delisted | Exer (M) | +15,000 | $27.1K | EDGAR |
| 2017-12-05 | CRISPR Therapeutics AG (PZRX) Delisted | Grant (A) | +26,667 | $509.9K | EDGAR |
| 2017-08-30 | CRISPR Therapeutics AG (PZRX) Delisted | Sell (S) | −27,154 | -$545.2K | EDGAR |
| 2017-05-05 | CRISPR Therapeutics AG (PZRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-28 | CRISPR Therapeutics AG (PZRX) Delisted | Mixed | — | -$81.9K | EDGAR |
| 2017-04-25 | CRISPR Therapeutics AG (PZRX) Delisted | Mixed | — | -$173.9K | EDGAR |
| 2017-04-21 | CRISPR Therapeutics AG (PZRX) Delisted | Mixed | — | -$160.2K | EDGAR |
Showing 101–110 of 110
Prev
Page 11 of 11
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.